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Objective: The prevalence of radiographic osteoarthritis (OA) after anterior cruciate ligament recon-
struction (ACLR) approaches 50%, yet the prevalence of signiﬁcant knee pain is unknown. We applied
three different models of Knee injury and Osteoarthritis Outcome Score (KOOS) thresholds for signiﬁcant
knee pain to an ACLR cohort to identify prevalence and risk factors.
Design: Multicenter Orthopaedic Outcomes Network (MOON) prospective cohort patients with a uni-
lateral primary ACLR and normal contralateral knee were assessed at 2 and 6 years. Independent vari-
ables included patient demographics, validated Patient Reported Outcomes (PRO; Marx activity score,
KOOS), and surgical characteristics. Models included: (1) KOOS criteria for a painful knee ¼ quality of life
subscale <87.5 and 2 of: KOOSpain <86.1, KOOSsymptoms <85.7, KOOSADL <86.8, or KOOSsports/rec <85.0; (2)
KOOSpain subscale score 72 (2 standard deviations below population mean); (3) 10-point KOOSpain
drop from 2 to 6 years. Proportional odds models (alpha  0.05) were used.
Results: 1761 patients of median age 23 years, median body mass index (BMI) 24.8 kg/m2 and 56% male
met inclusion, with 87% (1530/1761) and 86% (1506/1761) follow-up at 2 and 6 years, respectively. At 6
years, n ¼ 592 (39%), n ¼ 131 (9%) and n ¼ 169 (12%) met criteria for models #1 through #3,
respectively. The most consistent and strongest independent risk factor at both time-points was
subsequent ipsilateral knee surgery. Low 2-year Marx activity score increased the odds of a painful
knee at 6 years.D. Wasserstein, University of Toronto Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, MG301, Toronto,
: 1-416-480-5886.
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lateral surgery at greatest risk. The relationship between pain and structural OA warrants further
study.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Anterior Cruciate Ligament (ACL) reconstruction (ACLR) is the
most effective and reproducible treatment for ACL injured patients
who want to return to cutting and pivoting sports1e3. More than
half of the patients undergoing ACLR will have concomitant pa-
thology, including injuries to the articular cartilage in more than
20%, lateral meniscal tears in up to 46% andmedial meniscal tears in
38%4.
An ACL tear is a known risk factor for the development of
osteoarthritis (OA)5. Intermediate and long-term follow-up of
ACLR patients has demonstrated a high prevalence of radio-
graphic ﬁndings consistent with post-traumatic OA6e8. Which
factors, including concomitant pathology, the original injury,
surgical techniques, or other as yet unidentiﬁed factors, are most
responsible for the development of radiographic changes is un-
known. A systematic review of studies including patients 5- to
10-years after ACLR6, found radiographic joint space narrowing in
0e13% of patients with intact menisci, and 21e48% in those who
had undergone either meniscectomy or repair. The meniscal
status was also demonstrated to be important in a systematic
review of non-reconstructed ACL injured patients7. Most studies,
however, are limited by poor follow-up and signiﬁcant hetero-
geneity in the classiﬁcation systems utilized to describe radio-
graphic OA.
Although the deﬁnitions can be challenging9,10, a systematic
review in 2011 demonstrated a relationship between structural
OA and symptomatic OA among high quality studies11. Studies
using Osteoarthritis Initiative (OAI) data have yielded further
insight. Oak et al.12 found a correlation between joint space nar-
rowing at study entry, and greater progression of narrowing over
the course of the study, with worse Patient Reported Outcomes
(PRO) at 4 years. Others have found weak correlations between
PRO and magnetic resonance image (MRI) conﬁrmation of joint
space narrowing13, but these correlations were highest for the
knee pain subscale of the Knee injury and Osteoarthritis Outcome
Score (KOOS).
A consensus expert panel developed a deﬁnition of patients
with a symptomatic knee signiﬁcant enough to seek medical
attention. This deﬁnition, based on threshold levels of KOOS sub-
scale scores14, was based on the long-term follow-up of patients
who previously underwent isolated partial meniscectomy with
intact cruciate ligaments. Other criteria for clinically signiﬁcant
knee pain that have been developed based on PRO, include the
KOOS Minimal Clinically Important Difference (MCID) of 8e10
points15, and the Osteoarthritis Research Society International
(OARSI) Standing Committee criteria for interventions of OA of the
knee (“OARSI responder criteria”) of 20 points16,17.
Given that many patients who undergo ACLR develop radio-
graphic OA, the main objective of this study was to identify the
prevalence of signiﬁcant knee pain by PRO after ACLR, using pub-
lished deﬁnitions and cut-offs for either symptomatic OA or clini-
cally signiﬁcant knee pain. The second objectivewas to identify risk
factors for developing a painful knee from patient, injury, and
surgical characteristics 6 years following an ACL reconstruction.Methods
Study design
Longitudinal prospective cohort (prognostic): The Multicenter
Orthopaedic Outcomes Network (MOON) cohort18. MOON is a
prospective, longitudinal, multicenter cohort study based in the
United States, and designed to examine short and long-term
prognosis after ACL reconstruction using validated patient-
reported outcomes. MOON was also designed to generate hypoth-
eses surrounding novel methods for improving outcomes after ACL
injury.Data sources
Participants completed a 13-page questionnaire providing pa-
tient demographics, a description of their injury, sports participa-
tion history, comorbidities and past medical history. Each
participant also completed validated general and knee speciﬁc in-
struments, including the KOOS19 and the Marx activity rating
scale20. Contained within the KOOS is the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC)21. All were
completed within 2 weeks of the surgery date.
Surgeons completed a standardized questionnaire, which
included detailed information regarding surgical technique, graft
choice, and concomitant meniscal and articular cartilage pathology
and treatment. The inter-rater reliability of grading systems for
articular cartilage (modiﬁed Outerbridge) and meniscal lesions
were previously validated among participating surgeons and found
to be high22,23. Meniscal pathology was classiﬁed by size, location,
partial vs complete tears and treatment (not treated, repaired,
resection and extent of resection).Cohort design
All patients (n ¼ 2222) who had undergone a unilateral primary
ACLR at a participating MOON institution (Vanderbilt University,
The Ohio State University, Washington University at St. Louis,
University of Iowa, the Cleveland Clinic, and the Hospital for Special
Surgery) between 2002 and 2005 were eligible for inclusion into
this study. All patients provided informed consent from their
respective institution. A prior exclusion criteria included previous
contralateral ACL reconstruction, simultaneous bilateral ACL
reconstruction, ACL repair, or a revision ACL reconstruction as the
index (enrollment) event. ACL revision patients report worse PRO
than primary ACL reconstruction patients4,24e26, and so were
excluded. ACL repair is an atypical treatment and was excluded.
Patients with a contralateral ACL reconstruction prior to initial
enrollment into the MOON cohort, or performed concurrently,
were excluded on the basis that this study's objective included
understanding how a subsequent contralateral reconstruction
would inﬂuence PRO for signiﬁcant knee pain. No patients were
excluded from analysis due to incomplete baseline data (all
n ¼ 2222 completed baseline PRO).
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We utilized previously published deﬁnitions of KOOS thresholds
for a symptomatic knee as described in the introduction. We built
three models, as follows:
1. Model #1. The primary model was deﬁned as the operational
deﬁnition of Englund et al.14 (“Englund model”) to distinguish
patients with sufﬁcient knee symptoms to seek medical care.
The Englund model is deﬁned as having a KOOS knee-related
quality of life (QoL) subscale 87.5 and two or more of the
other subscales: KOOS pain86.1, KOOS symptoms85.7, KOOS
activities of daily living (ADL) 86.8, or KOOS sports and rec-
reation (“sport/rec”) 85.0.
2. Model #2. The KOOS knee pain subscale has been shown to have
the highest correlation with structural OA changes13, and is a
direct measure of knee pain. Therefore, we deﬁned a secondary
model for signiﬁcant knee pain as a KOOS pain subscale two
standard deviations lower than the reported normal mean value
in athletic populations with a history of (any) knee ligament
injury. This value was 92.3 ± 10.024, which translated into a cut-
off score of72 points (“KOOS pain72model”). This deﬁnition
also qualiﬁed as a 20-point change, consistent with OARSI
responder criteria for effective interventions in OA16.
3. Model #3. The reported MCID for the KOOS pain subscale is 6.1
points in athletes after ACL reconstruction27, to between 8 and
10 points for patients with OA15,28. To utilize a more conserva-
tive estimate of the MCID, we selected a drop of 10 points in the
KOOS pain subscale from 2 years to 6 years follow-up as an
additional secondary deﬁnition of patients with a painful knee
after ACL reconstruction (“KOOS pain MCID model”). This model
attempted to identify patients who had a clinically signiﬁcant
worsening of knee pain.Model variables
Variables included all those from the original MOON cohort.
They included patient demographics (age, sex, body mass index
[BMI], smoking status, education level, main sport played at the
time of injury, enrollment year), validated PRO (KOOS, WOMAC,
Marx activity), surgical characteristics (graft type, meniscal pa-
thology/treatment, articular cartilage pathology), and incidence of
subsequent surgery on either knee (Table I). The Marx score is a
measure of the frequency and intensity of cutting and pivoting
sports. The inclusion of variables in our models was based on
substantive knowledge of the clinical or epidemiological associa-
tion between them and PRO after ACL reconstruction surgery. These
relationships have been established by our own work with this
cohort4,7,18,24 and have been derived from literature review18. They
extend to include baseline PRO scores, patient demographic factors
and surgical variables.
Statistical analysis
To describe our patient sample, we summarized continuous
variables as percentiles (i.e., 25th, 50th, and 75th) with their mean
and standard deviation, and categorical variables with frequencies
and percentages. Multivariable regression analyses were con-
structed to examine which baseline risk factors were indepen-
dently associated with each outcome variable. An a priori
determined list of variables to be included in all models were given
by: age, gender, BMI, smoking status, education level, main sport
played the last 2 years, baseline KOOS, WOMAC, and Marx activity
levels, graft type, previous meniscal pathology, current meniscalpathology/treatment, previous articular cartilage pathology, cur-
rent articular cartilage pathology, subsequent surgery on the ipsi-
lateral and contralateral knee, and enrollment year. We assumed
independence of all covariates because we compared between
subjects and not within, and when ﬁtting the multivariable
regression models, we measured each covariate's independent
adjusted association with the outcome. For binary outcome vari-
ables a multivariable logistic regression model was ﬁt to the data,
parameter estimates were exponentiated to obtain odds ratios (OR)
and 95% conﬁdence intervals (CI), based on a dichotomous outcome
(yes/no). We did not assume a linear relationship between
continuous covariates (independent variables) and each outcome
in order to avoid underestimating the true relationship, instead
utilized a restricted cubic regression splines technique that as-
sumes smooth relationships (i.e., they are linearly related to the log
odds). To avoid case-wise deletion of records with missing cova-
riates, we employed multiple imputation via predictive mean
matching. All model assumptions (as listed above) were met. Sta-
tistical analysis was performed using open source R statistical
software (www.r-project.org; Version 3.0.3).
Post hoc analysis
Preliminary ﬁndings demonstrated that a low Marx activity
score at 2 years increased the odds of reporting a painful knee in
both the Englund and KOOS pain72models. Therefore, in order to
further understand the interaction of pain and activity, we per-
formed a post hoc analysis to identify the proportion of patients
reporting a high level of sport/activity-related knee pain, and to
understand which factors modiﬁed that outcome. This model uti-
lized responses from a 5-point Likert question on the International
Knee Documentation Committee (IKDC): “What is the highest level
of activity that you can perform without signiﬁcant knee pain?”
Patients were classiﬁed based on their answer to this question as
high activity tolerance (“very strenuous activities” or “strenuous
activities” or “moderate activities”) or low activity tolerance (“light
activities” or “no described activities”). Models were built for this
outcome (Model #4: “Activity tolerance model”) at 6 years based
on the response to the question at 2 years.
After determining that subsequent ipsilateral surgery was a risk
factor, we performed a second post-hoc analysis to identify the
number of patients who underwent a second surgery within 1 and
3 months prior to the 2- and 6-year time-points. This was per-
formed due to concern that recent surgery may be the cause of
higher reported pain. Furthermore, we re-analyzed each of the four
models after excluding the patients with surgery within 3 months
of the 2- and 6-year time-points.
Results
Figure 1 illustrates the cohort inclusion/exclusion criteria. There
were 1761 subjects who ﬁt the inclusion criteria and were included
in this analysis. The median age of our cohort was 23 years, median
BMI 24.8 kg/m2 and the cohort was 56% male. Patient follow-up
was obtained on 87% (1530/1761) and 86% (1506/1761) at 2 and 6
years, respectively. The proportion of patients who met each of the
three model criteria was calculated (see Table III). At 2 years, n ¼ 46
patients ﬁt both the Englund and KOOS pain72 pointsmodels, out
of a total n ¼ 141 possible patients (32.6%). At 6 years, n ¼ 67 pa-
tients ﬁt all four models, out of a total n ¼ 131 possible (51%). Full
baseline demographics are supplied in Table II alongside the list of
model variables and levels.
Table III depicts the signiﬁcant independent risk factors identi-
ﬁed in each model. Subsequent ipsilateral surgery was the most
consistent and strongest predictor of increased symptoms at both 2
Table I
List of modeling variables
Category Levels
Baseline outcome scores KOOS (5 subscales); WOMAC
(pain, stiffness subscales)
Continuous
Patient demographics Age (years) Continuous
Gender Male, female
BMI Continuous
Smoking status Never, quit, current
Education level (years) 1e16 (continuous)
Baseline activity level (Marx) Continuous
Main sport played last 2 yrs Basketball, football, soccer, other, none
Surgical variables Graft type Autograft (BTB), autograft (soft tissue), allograft (BTB), allograft (soft tissue)
Meniscal pathology
* Previous No, yes
* Medial Normal, no tx for tear, repair, excised, other
* Lateral Normal, no tx for tear, repair, excised, other
Articular cartilage pathology
* Previous No, yes
* Medial femoral condyle (MFC) Normal/grade 1, grade 2, grade 3, grade 4
* Lateral femoral condyle (LFC) Normal/grade 1, grade 2, grade 3, grade 4
* Medial tibial plateau (MTP) Normal/grade 1, grade 2, grades 3/4
* Lateral tibial plateau (LTP) Normal/grade 1, grade 2, grades 3/4
* Patella Normal/grade 1, grade 2, grades 3/4
* Trochlea Normal/grade 1, grade 2, grades 3/4
Miscellaneous variables Year of surgery (enrollment) 2002, 2003, 2004, 2005
Subsequent ipsilateral surgery No, arthroscopic procedure, revision ACL reconstruction, total knee arthroplasty (TKA)
Subsequent contralateral surgery No, arthroscopic procedure, ACL reconstruction, total knee arthroplasty (TKA)
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Fig. 2). Subsequent surgeries were common, occurring at a rate of
16% (239/1530) at 2 years and 21.5% (324/1506) at 6 years. The
majority of subsequent surgeries other than total knee replacement
took place more than a year prior to the 6 year outcome mea-
surement. The mean time to revision ACLR was 2.4 ± 1.9 years, totalAssessed for
n=222
Final baselin
n=176
2 years
655/1527 (43%)
6 years
592/1505 (39%)
Model #2
(KOOS pain <72)
Model #1
(Englund)
2 years
141/1528 (9%)
6 years
131/1504 (9%)
2 Year follow-up
n=1530 (87%)
Fig. 1. Flowchart showing the inclusknee replacement 5.3 ± 2.2 years and other arthroscopic surgical
procedures 2.1 ± 1.9 years. Revision ACLR was the single most
common subsequent procedure. The vast majority of subsequent
procedures took place remote from sampled time-points: only 1.3%
(3/239) and 0% (0/324) of patients had a subsequent surgery within
1 month of ﬁlling out the KOOS forms at 2 years and 6 years, eligibility
2
Excluded:
• Bilaterals (n=13)
• ACL revisions (n=228)
• ACL repairs (n=75)
• Previous contralateral ACL 
reconstruction (n=145)
e cohort
1
Model #4
(Activity Tolerance)
Model #3
(KOOS pain MCID)
6 years
169/1394 (12%)
6 years
159/1495 (11%)
6 Year follow-up
n=1506 (86%)
ion of participants in the study.
Table II
Baseline data for the included cohort and the patients lost to follow-up
Category Variable (N) Level Overall cohort (n ¼ 1761)
n (%) or median (25the75th)
Lost to follow-up @ 2 yrs (n ¼ 231)
n (%) or median (25the75th)
Lost to follow-up @ 6 yrs (n ¼ 255)
n (%) or median (25the75th)
Patient demographics Sex Male 980 (56%) 146 (63%) 169 (66%)
Female 781 (44%) 85 (37%) 86 (34%)
Age Continuous 23 years (17e35) 22 years (17e30) 22 years (17e32)
BMI Continuous 24.8 kg/m2 (22.3e27.9) 25.4 kg/m2 (22.9e29.2) 26.4 kg/m2 (23.2e29.9)
Smoking status Current 167 (10%) 32 (15%) 44 (18%)
Quit smoking (>6 months) 172 (10%) 15 (7%) 16 (6%)
Never smoker 1354 (80%) 171 (78%) 186 (76%)
Education level Continuous 14.0 years (11.0e16.0) 13.0 years (11.0e16.0) 12.0 years (10.0e16.0)
Main sport Basketball 393 (23%) 61 (27%) 69 (27%)
Football 191 (11%) 38 (17%) 35 (14%)
Soccer 230 (13%) 17 (7%) 20 (8%)
Other 793 (46%) 99 (43%) 106 (42%)
None 134 (8%) 14 (6%) 22 (9%)
PRO Marx activity Baseline 12 (8e16) 13 (9e16) 13 (8e16)
2 years 9 (4e13) N/A 8 (1e12)
KOOS symptoms Baseline 68 (57e82) 68 (50e79) 68 (50e82)
KOOS pain Baseline 75 (64e89) 69 (58e86) 72 (58e86)
KOOS ADL Baseline 88 (74e96) 83 (68e94) 82 (65e94)
KOOS Sports & rec Baseline 50 (30e75) 50 (25e75) 50 (25e75)
KOOS QoL Baseline 38 (25e50) 31 (19e50) 31 (19e44)
WOMAC stiffness Baseline 75 (62e88) 75 (50e88) 75 (50e88)
WOMAC pain Baseline 90 (75e95) 85 (70e95) 85 (65e95)
Surgical/Injury factors Previous meniscal pathology No 1632 (93%) 210 (91%) 230 (90%)
Yes 129 (7%) 21 (9%) 25 (10%)
Previous articular cartilage pathology No 1739 (99%) 228 (99%) 249 (98%)
Yes 22 (1%) 3 (1%) 6 (2%)
Graft type Allograft (BTB) 121 (7%) 16 (7%) 27 (11%)
Allograft (soft tissue) 299 (17%) 39 (17%) 35 (14%)
Autograft (BTB) 832 (47%) 116 (51%) 120 (47%)
Autograft (soft tissue) 509 (29%) 60 (26%) 73 (29%)
Medial meniscus treatment Normal/none 1106 (63%) 149 (65%) 173 (68%)
Tear/no treatment 94 (5%) 10 (4%) 10 (4%)
Repair 229 (13%) 39 (17%) 35 (14%)
Partial excision 317 (18%) 33 (14%) 37 (15%)
Other 15 (1%) 0 (0%) 0 (0%)
Lateral meniscus treatment Normal/none 927 (53%) 118 (51%) 127 (50%)
Tear/no treatment 197 (11%) 25 (11%) 25 (10%)
Repair 128 (7%) 16 (7%) 22 (9%)
Partial excision 497 (28%) 72 (31%) 80 (31%)
Other 12 (1%) 0 (0%) 1 (<1%)
Medial femoral condyle Normal/grade 1 1381 (78%) 189 (82%) 202 (79%)
Grade 2 225 (13%) 30 (13%) 31 (12%)
Grade 3 117 (7%) 8 (3%) 15 (6%)
Grade 4 38 (2%) 4 (2%) 7 (3%)
Lateral femoral condyle Normal/grade 1 1498 (85%) 197 (85%) 209 (82%)
Grade 2 186 (11%) 24 (10%) 32 (13%)
Grade 3 59 (3%) 10 (4%) 11 (4%)
Grade 4 18 (1%) 0 (0%) 3 (1%)
Medial tibial plateau Normal/grade 1 1694 (96%) 228 (99%) 250 (99%)
Grade 2 45 (3%) 1 (<1%) 1 (<1%)
Grades 3e4 22 (1%) 0 (0%) 0 (0%)
Lateral tibial plateau Normal/grade 1 1611 (91%) 215 (94%) 230 (92%)
Grade 2 122 (7%) 13 (6%) 20 (8%)
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D. Wasserstein et al. / Osteoarthritis and Cartilage 23 (2015) 1674e1684 1679respectively. Furthermore, only 3.8% (9/239) and 1.2% (4/324) of
patients had a subsequent surgery within 3 months of ﬁlling out
the KOOS forms at 2 years and 6 years, respectively. When all four
models were re-run with patients who had undergone subsequent
surgery within 3 months removed, no changes were noted in the
signiﬁcance or magnitude of any statistically signiﬁcant risk factors.
One risk factor in model #4 which previously approached signiﬁ-
cance then became signiﬁcant (current vs never smoker: OR 1.82
(1.02, 3.27); P ¼ 0.043).
Other independent risk factors that were found to be signiﬁcant
(although inconsistent) of increased symptoms at 2 and/or 6 years
post-ACL reconstruction included higher BMI, smokers, less years
of education, lower baseline KOOS ADL and higher baseline KOOS
sports/rec subscale scores, and lower 2-year Marx activity levels
(for predicting the 6-year models).
Potential prognostic factors that did not alter the risk of
reporting a painful knee or having signiﬁcant activity-related pain
included age, pre-operative/baseline activity level, pre-operative
WOMAC (pain, stiffness) or KOOS (symptoms, pain, and QoL)
baseline scores, graft type, medial meniscal pathology/treatment,
and subsequent contralateral knee surgery. The grade of chondral
damage at initial arthroscopy was an inconsistent predictor in the
patellofemoral, medial and lateral compartments. In general, when
chondral damage inﬂuenced the odds of reporting either a painful
knee or signiﬁcant activity-related pain, the tendency was for the
effect to be driven by grade 3/4 change.
Discussion
The prevalence of signiﬁcant patient-reported knee pain 6 years
after ACLRwas high, including 39% by the Englund deﬁnition, 9% for
KOOS pain score 72 (drop 20 points) and 12% for KOOS pain
MCID deﬁnition (drop 10 points). A similar proportion of patients
(11%) reported signiﬁcant activity-related knee pain at 6 years. This
study is the ﬁrst to apply these deﬁnitions to characterize this pa-
tient population and represents an important ﬁrst step in identi-
fying at-risk patients for the development of signiﬁcant knee pain
after ACLR.
The most consistent risk factor across all deﬁnitions of signiﬁ-
cant knee pain also carried the largest impact e subsequent ipsi-
lateral knee surgery.We utilized interactions of age and subsequent
surgery in our statistical modeling because of our previous ﬁnd-
ings4 that demonstrated younger age increased the risk of subse-
quent surgery at 2 and 6 year follow-up. This limited the degrees of
freedom we could use to identify which of the subsequent pro-
cedures had the most inﬂuence. At 6 years, ipsilateral re-operation
was dominated by revision ACLR, further meniscus/articular carti-
lage surgery and surgical interventions for stiffness. Revision ACLR
has been associated with worse PRO4,24e26, and subsequent
meniscal or articular cartilage surgery is a recognized risk for
radiographic OA changes in ACL reconstructed patients6. The
identiﬁcation of subsequent surgery as a risk factor for reporting a
painful kneewas also a robust enough ﬁnding that it held evenwith
the removal of patients who had surgery within 3 months of the 2-
and 6-year time-points from statistical analysis. That contralateral
knee surgery did not increase the odds of reporting a painful knee,
places further importance on subsequent surgeries as a marker for
additional trauma or joint degeneration as a driver of poor out-
comes. Better resolution of the type of procedure in subsequent
investigations will be helpful, as some are potentially preventable
through improved surgical technique, timing of surgery, or
rehabilitation.
Many ACLR patients exhibited activity-related knee pain in
follow-up. We assessed this using model #4, and determined that
11% of patients met these criteria. This included approximately half
Table III
Summary of Independent Variables [reported as OR (95% CI); bolded and P-value included when signiﬁcant]
Category Variable comparison Variable (worse
outcome, if signiﬁcant)
Model 1 (Englund) Model 2 (KOOS Pain  72) Model 3
(KOOS Pain MCID)
Model 4
(Activity tolerance)
2 years 6 years 2 years 6 years 6 years 6 years
Number of patients
who satisﬁed
criteria for each
model
655/1527 (43%) 592/1505 (39%) 141/1528 (9%) 131/1504 (9%) 169/1394 (12%) 159/1495 (11%)
Baseline outcome
scores
KOOS Symptoms 0.90 (0.69, 1.18) 0.83 (0.69, 1.09) 0.78 (0.45, 1.36) 0.81 (0.45, 1.49) 0.91 (0.59, 1.40) 1.27 (0.78, 2.07)
Pain 0.66 (0.40, 1.07) 0.78 (0.46, 1.32) 0.48 (0.17, 1.36) 0.87 (0.32, 2.37) 1.45 (0.66, 3.18) 1.00 (0.40, 2.51)
ADL ADL (low) 0.53 (0.36, 0.79)
P < 0.001
0.67* (0.45, 0.99)
P ¼ 0.117
0.78 (0.37, 1.62) 0.89 (0.42, 1.89) 1.13 (0.61, 2.07) 0.67 (0.32, 1.41)
Sports/Rec Sports/Rec (high) 1.04 (0.82, 1.32) 1.01 (0.77, 1.33) 1.63 (1.13, 2.34)
P ¼ 0.016
0.78 (0.53, 1.16) 0.90 (0.63, 1.30) 0.88 (0.60, 1.29)
QoL 0.90 (0.76, 1.06) 0.97 (0.82, 1.15) 0.96 (0.73, 1.27) 1.00 (0.73, 1.36) 0.82 (0.64, 1.04) 0.79 (0.60, 1.04)
WOMAC Pain 1.18 (0.77, 1.81) 1.09 (0.69, 1.72) 0.68 (0.31, 1.47) 0.46 (0.20, 1.05) 0.63 (0.29, 1.35) 1.03 (0.50, 2.13)
Stiffness 0.92 (0.74, 1.15) 0.92 (0.72, 1.16) 1.06 (0.70, 1.59) 1.57 (1.00, 2.47) 1.07 (0.73, 1.58) 0.92 (0.62, 1.36)
Patient
characteristics
Age (yrs) Age 0.91 (0.55, 1.51) 0.76 (0.42, 1.37) 1.65 (0.73, 3.71) 1.21 (0.48, 3.05) 0.96 (0.42, 2.17) 1.43 (0.62, 3.28)
Gender Females: Males Males 1.10 (0.86, 1.40) 1.00 (0.75, 1.33) 0.85 (0.54, 1.34) 0.90 (0.54, 1.51) 0.67 (0.47, 0.96)
P ¼ 0.028
1.46 (0.89, 2.39)
BMI BMI Higher BMI 1.24 (1.01, 1.53)
P ¼ 0.004
1.28* (1.01, 1.61)
P ¼ 0.071
1.52 (1.04, 2.20)
P ¼ 0.003
1.30 (0.84, 2.02) 1.00 (0.71, 1.39) 1.27 (0.89, 1.83)
Smoking status Current: Never Current (compared to
never)
1.45 (0.96, 2.19) 1.22 (0.81, 1.85) 1.59 (0.92, 2.75) 2.83 (1.46, 5.49)
P ¼ 0.002
1.13 (0.62, 2.08) 1.78 (1.00, 3.18)
Quit: Never Quitting (compared to
never)
1.66 (1.12, 2.45)
P ¼ 0.011
0.84 (0.54, 1.32) 0.96 (0.50, 1.83) 1.96 (1.02, 3.75)
P ¼ 0.042
0.59 (0.32, 1.12) 1.03 (0.57, 1.89)
Education (years) Years of education Less education years 1.04 (0.77, 1.41) 0.80 (0.56, 1.14) 0.63 (0.38, 1.03) 0.43 (0.23, 0.79)
P ¼ 0.022
0.72 (0.44, 1.16) 0.61* (0.39, 0.98)
P ¼ 0.126
Baseline activity
level (Marx)
Marx activity score 1.31 (0.92, 1.87) 1.16 (0.80, 1.69) 1.38 (0.72, 2.65) 1.39 (0.66, 2.92) 0.93 (0.53, 1.63) 1.26 (0.60, 2.67)
2 year activity level
(Marx)
Marx activity score Low score (low activity) e 0.62 (0.48, 0.82)
P ¼ 0.001
e 0.53 (0.33, 0.86)
P ¼ 0.032
0.91 (0.64, 1.31) 0.41 (0.26, 0.63)
P < 0.001
Surgical factors Previous meniscal
pathology
Yes: No No (compared to ‘yes’) 1.48 (0.91, 2.39) 1.23 (0.76, 1.98) 1.11 (0.57, 2.16) 1.13 (0.51, 2.52) 0.43 (0.19, 0.97)
P ¼ 0.041
1.78 (0.90, 3.51)
Previous articular
cartilage pathology
Yes: No 3.98 (0.95, 16.73) 0.70 (0.20, 2.50) 2.50 (0.70, 8.86) 1.79 (0.46, 6.93) 0.53 (0.08, 3.55) 3.47 (0.58, 20.63)
Current meniscal
pathology
* Medial Repair: Normal 1.34 (0.94, 1.90) 1.11 (0.79, 1.55) 1.53 (0.90, 2.60) 1.61 (0.91, 2.86) 0.96 (0.59, 1.59) 1.21 (0.65, 2.25)
* Lateral No tear for treatment:
Normal
Normal (compared to
no tx for tear)
0.59 (0.39, 0.89)
P ¼ 0.012
0.74 (0.50, 1.10) 0.97 (0.50, 1.89) 0.62 (0.28, 1.40) 0.93 (0.52, 1.67) 1.22 (0.65, 2.30)
Current Articular
cartilage pathology
* Medial femoral
condyle (MFC)
Grade 4: Normal/grade
1
Grade 4 (compared
with normal/grade 1)
1.62 (0.69, 3.76) 1.43 (0.65, 3.14) 1.07 (0.35, 3.32) 1.28 (0.46, 3.61) 1.42 (0.50, 3.98) 2.67 (1.05, 6.80)
P ¼ 0.040
* Lateral femoral
condyle (LFC)
Grade 2: Normal/grade
1
Normal/grade 1
(compared to grade 2)
0.70 (0.47, 1.05) 0.73 (0.48, 1.09) 0.75 (0.36, 1.57) 0.34 (0.14, 0.82)
P ¼ 0.016
0.83 (0.46, 1.49) 1.01 (0.53, 1.92)
Grade 3: Normal/grade
1
Grade 3 (compared
with normal/grade 1)
1.78 (0.85, 3.73) 2.58 (1.21, 5.50)
P ¼ 0.014
1.40 (0.54, 3.62) 1.37 (0.44, 4.29) 1.89 (0.83, 4.32) 1.56 (0.47, 5.19)
* Medial tibial
plateau (MTP)
Grades 3/4: Normal/
grade 1
Grades 3/4 (compared
with normal/grade 1)
0.73 (0.24, 2.27) 2.98 (0.93, 9.50) 1.26 (0.35, 4.53) 3.20 (0.76, 13.48) 4.20 (1.33, 13.25)
P ¼ 0.015
0.86 (0.17, 4.25)
* Lateral tibial
plateau (LTP)
Grade 2: Normal/grade
1
Normal/grade 1
(compared to grade 2)
0.91 (0.57, 1.46) 0.46 (0.26, 0.82)
P ¼ 0.008
0.41 (0.15, 1.14) 1.24 (0.53, 2.93) 1.15 (0.60, 2.22) 0.56 (0.24, 1.35)
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Fig. 2. Subsequent ipsilateral surgical procedures at 6 years (“Other arthroscopic”
includes hardware removal, meniscal and articular cartilage surgery, infection,
arthrolysis/manipulation).
D. Wasserstein et al. / Osteoarthritis and Cartilage 23 (2015) 1674e1684 1681who also met criteria for models #2 and #3 e both KOOS pain
models. KOOS pain assesses both activity-related and non-activity
related pain and contains the questions from the validated hip
and knee OA tool e WOMAC15. Furthermore, we noted that a low
Marx score at 2 years increased the odds of a patient meeting the
Englund criteria (model #1), KOOS pain 72 criteria (model #2),
and IKDC activity-related pain threshold (model #4). Whether
simply being less active is a risk factor for reporting signiﬁcant knee
pain, or whether patients already developing signiﬁcant knee pain
become less active, is not known.
There is no consensus deﬁnition for symptomatic OA or signif-
icant knee pain using PRO. This is further complicated by the het-
erogeneity of diagnoses/deﬁnitions reported in the literature.
While we found the prevalence of signiﬁcant knee painwas high, it
varied considerably based on our deﬁnitions. The Englund et al.14
criteria were the least stringent, but also the broadest including
pain, symptoms and QoL reporting. The KOOS pain threshold in that
model was 86 points, which corresponded to the 25th percentile of
KOOS pain scores in the MOON cohort4. Accordingly, this model
identiﬁed the most patients. Few cues are available from the liter-
ature for prevalence of pain based on the Englund model in similar
patients, with only two small published studies. In a cohort of 84
female soccer players with an ACL injury treated with either
rehabilitation or surgery29, 75%met the Englund criteria at 15 years
follow-up. In contrast, 51% met criteria for knee OA on radiographs,
and 42% met both. In a purely non-operative cohort30 of 67 ACL
injured patients, the 15-year KOOS pain scores were all 85 points or
greater.
The 20-point drop in KOOS pain score that we selected corre-
sponded to the OARSI responder criteria16 and 2 standard de-
viations below themean of KOOS scores of athletes with a history of
knee ligament injury31. Even fewer comparative studies exist in the
literature for this deﬁnition. Paradowski et al.17 applied the OARSI
responder criteria, developed for use in OA interventional studies to
identify therapies that produce signiﬁcant knee pain reduction, to
identify mild OA patients with signiﬁcantly increased knee symp-
toms post-meniscectomy. Those with radiographic changes had a
larger drop in KOOS pain score (11 points), and by 6 years they
determined that 7% of patients had a 20 point KOOS pain drop.
Another study of older, post-meniscectomy patients with intact
ligaments demonstrated a mean baseline KOOS pain of 84 points32,
but with high individual variation. Seven years later the same pa-
tients reported a further six point drop in KOOS pain on average
which was worse in females and those with radiographic changes.
D. Wasserstein et al. / Osteoarthritis and Cartilage 23 (2015) 1674e16841682A 20-point KOOS pain drop that is two standard deviations
below population norms31 should theoretically include only 2.5% of
our cohort. In fact, however, the distribution of KOOS pain was
skewed to the left at 6 years with more than 9% of patients having a
score below this cut-off. This ﬁnding offers both clinical and sta-
tistical signiﬁcance and reinforces the role of subsequent injury,
joint degeneration, or concomitant pathology at the primary
reconstruction in the identiﬁcation of patients at-risk for high
levels of self-reported knee pain. Furthermore, a signiﬁcant pro-
portion of these patients reported high levels of activity-related
pain according to our IKDC model #4 deﬁnition.Factor Contributor
Study design/conception DW, LJH, KPS
Acquisition of data LJH
Analysis and interpretation of data DW, LJH, SN, KPS
Drafting of manuscript DW
Critical revision for intellectual content DW, LJH, KPS
Final approval DW, LJH, KPS
Provision of study materials or patients AA, JTA, WRD, CCK, RM, ECM,
RDP, KPS, MLW, BRW, RWW
Statistical expertise SN
Obtaining of funding KPS
Administrative, technical or logistic support ?
Collection and assembly of data AA, JTA, WRD, LJH, CCK, RM,
ECM, RDP, KPS, MLW, BRW,
RWWLimitations
There are some challenges in comparing our cohort with pre-
vious studies that have attempted to develop and characterize the
prevalence of signiﬁcant knee pain. Prior studies have examined
patients with a different primary surgical intervention e namely
meniscectomy14,17,32,33. The etiology of meniscal tears in those co-
horts included both traumatic and atraumatic mechanisms,
whereas our cohort had sustained a traumatic rupture of the ACL.
Secondly, the meniscectomy cohorts have an older mean age than
our cohort (mean age typically 46e56 years, compared tomean age
<30 years at follow-up in our study). How a degenerative process
and traumatic process modify the risk of developing knee OA is
unknown.
Loss to follow-up in our study was 13% (2 year) or 14% (6 year).
Although there is no consensus on the introduction of bias based on
follow-up, most estimates suggest that <5% loss will have no effect,
while >20% may pose serious threats to validity34. Yet the direction
and approximate magnitude of some covariates, such as socioeco-
nomic markers, do not change with attrition approaching even
50%35,36. MOON investigators go to considerable length to contact
enrolled patients, including repeated mailings and phone calls. As
noted in Table III, the proportion of males lost to follow-up was
slightly higher (63% vs 56%), and some minor differences were seen
for BMI and smoking status. We don't think this will have had a
large effect on the study conclusions, as sex was not associated with
outcome, smoking was inconsistently associated with only a couple
outcomes and BMI was only a predictor in model #1.
Our study was not designed to identify the best deﬁnition for a
symptomatic knee. Accordingly, we utilized various deﬁnitions,
each with advantages and disadvantages as well as mixed support
in the literature. The agreement betweenmodels was reasonable at
6 years after ACLR, as exempliﬁed by identifying approximately half
of the patients (n ¼ 67) from the most stringent model (KOOS pain
72; n ¼ 131) in the remaining models. The identiﬁcation of which
outcomes (pain, function, or ADL) remain most important to post-
ACLR patients, and the establishment of cut-off scores using the
Patient Acceptable Symptomatic State (PASS) concept for ACLR will
be important steps in further deﬁning this subset of patients.
Finally, we did not have radiographs available in follow-up of
these patients to correlate structural change with symptomatic
ﬁndings, as has been done in smaller series post isolated menis-
cectomy17,29,32,37,38. The interaction of structural changes with
symptoms is an important area for future research. This is height-
ened by the discordance between our study and systematic reviews
of post-ACL reconstruction patients6 that suggests meniscal pa-
thology at the time of injury/surgery moderates radiographic OA
risk. It would appear that while meniscal loss initiates joint space
changes, it may be a weaker mediator of symptoms compared to
other factors we have identiﬁed such as chondral damage and
subsequent injury/surgery. There is some support for this notionbased upon weak associations demonstrated between joint space
narrowing and poor PRO in OAI cohort studies12,13. A second
explanation is that the follow-up in our study is not yet long
enough for meniscal status at the time of surgery to have the same
inﬂuence on PRO. Exploring these interactions in future work is of
critical importance to deﬁne the patients truly at-risk for clinically
relevant OA after ACL reconstruction.
Summary
Signiﬁcant knee pain and symptoms is prevalent among 9e39%
of ﬁrst-time ACL reconstruction patients at 6 years. Patient-
reported pain is affected to some degree by demographic factors
and higher grades of concurrent cartilage damage at the index
procedure, however, those who undergo second surgeries (e.g.,
revision, repeat arthroscopy) are at greatest risk. Whether this
patient report of signiﬁcant knee pain relates to structural arthritic
changes requires further study.
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